Anti-NQO1 antibody (Ab34173)
DIA4, NMOR1, NQO1, NAD(P)H dehydrogenase [quinone] 1, Azoreductase, DT-diaphorase, Menadione reductase, NAD(P)H:quinone oxidoreductase 1, Phylloquinone reductase, Quinone reductase 1, DTD, QR1
反应种属：Human
抗原名称：NQO1
应用：WB, IF/ICC
详细信息
免疫原The exact immunogen used to generate this antibody is proprietary information.
宿主/亚型Rabbit / IgG
抗体类型Polyclonal
产品形式Liquid
纯化方式Affinity purification Immunogen
储存缓冲液pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
储存条件运输条件: Blue Ice
推荐的短期储存时间: 1-2 weeks
推荐的短期储存条件: +4°C
推荐的长期储存条件: -20°C
储存信息: Avoid freeze / thaw cycle
文献引用 (166)
Chemical knockdown of Keap1 and homoPROTAC-ing allergic rhinitis.
Keap1 的化学敲除和 homoPROTAC 引起的过敏性鼻炎
Serine ubiquitination of SQSTM1 regulates NFE2L2-dependent redox homeostasis
SQSTM1 的丝氨酸泛素化调节 NFE2L2 依赖的氧化还原稳态
KEAP1 retention in phase-separated p62 bodies drives liver damage under autophagy-deficient conditions.
在自噬缺陷的情况下，KEAP1 在相分离的 p62 小体中的滞留会导致肝损伤
Exploiting NRF2-ARE pathway activation in papillary renal cell carcinoma
利用NRF2-ARE通路激活治疗乳头状肾细胞癌
Soy Isoflavones Protects Against Stroke by Inhibiting Keap1/NQO1/Nrf2/HO-1 Signaling Pathway: Network Pharmacology Analysis Combined with the Experimental Validation.
大豆异黄酮通过抑制 Keap1/NQO1/Nrf2/HO-1 信号通路来预防中风：网络药理学分析与实验验证相结合
Luteolin delays the progression of IgA nephropathy by attenuating inflammation, oxidative stress and reducing extracellular matrix accumulation through activating the Nrf-2/HO-1 pathway.
木犀草素通过激活 Nrf-2/HO-1 通路，减轻炎症、氧化应激并减少细胞外基质的积累，从而延缓 IgA 肾病的进展
Tanshinlactone triggers methuosis in breast cancer cells via NRF2 activation
丹参内酯通过激活 NRF2 引发乳腺癌细胞中的甲基化
Blockade of the estrogen receptor alpha-pregnane X receptor axis protects ovariectomized mice against ethanol-induced hepatotoxicity.
阻断雌激素受体α-孕烷X受体轴可保护卵巢切除小鼠免受乙醇引起的肝毒性
Alpha-Lipoic Acid and Metformin Combination Therapy Synergistically Activate Nrf2-AMPK Signaling Pathways to Ameliorate Cognitive Dysfunction in Type 2 Diabetic Encephalopathy: A Preclinical Study.
α-硫辛酸和二甲双胍联合疗法协同激活 Nrf2-AMPK 信号通路，改善 2 型糖尿病脑病认知功能障碍：一项临床前研究
- 1
- 2
- 3
- 4
- 5
- 6
- 17